Salidroside suppresses the activation of nasopharyngeal carcinoma cells via targeting miR-4262/GRP78 axis
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
To study the effect of Salidroside on nasopharyngeal carcinoma (NPC) cells and its mechanism. NPC cells were cultured, MTT was used to detect the effect of Salidroside on cell proliferation, apoptosis detected by flow cytometry assay, Western blot was used to detect the related protein expression. MiR-4262 and GRP78 used qRT-PCR for evaluation. Mimics/mimic NC and miR-4262 inhibitor/inhibitor NC were transfected into CNE2 and HONE1 cell lines, and cell viability was detected by MTT. Caspase-3, -8 and -9 activities were detected by caspase colorimetric assay kit. Targetscan predicted that downstream target of miR-4262. Relative luciferase activity was detected by luciferase assay. The effect of Salidroside on the growth of transplanted tumor in nude mice was observed. After Salidroside treatment, cell proliferation decreased and apoptosis increased, Bax protein expression increased and Bcl-2 decreased; miR-4262 expression level in nasopharyngeal carcinoma tissues was lower than that in adjacent tissues. GRP78 was the target of miR-4262 and downregulate the expression of miR-4262 in NPC cells can increase the expression of GRP78, and the expression of GRP78 decreased after upregulating the expression of miR-4262. Salidroside could inhibit the growth of NPC xenografts in nude mice. The level of Bax was increased and Bcl-2 was decreased in Salidroside group. Salidroside can significantly inhibit the proliferation and promote the apoptosis of NPC cells via regulating miR-4262/GRP78 signal axis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, salidroside treatment has been shown to inhibit the proliferation of nasopharyngeal carcinoma (NPC) cells, including the CNE2 and HONE cell lines, through regulation of the miR-4262/GRP78 axis.79”
From Drug repurposing for cancer therapy (2024) · cites this paper as [79]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109 · cited 2×
“The incidence rate of NPC is significantly higher than that of 30 years old and reaching a peak at 50 – 59 years old [2].”
BackgroundChen, Y.-P., Chan, A. T. C., Le, Q.-T., Blanchard, P., Sun, Y., & Ma, J. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30956-0 · Cited by 3,077
Wang, M., Wey, S., Zhang, Y., Ye, R., & Lee, A. S. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2485 · Cited by 609 · cited 1×
“between cancer cell survival and apoptosis [36].”
Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential
Lee, A. S. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3701 · Cited by 587
Arap, M. A., Lahdenranta, J., Mintz, P. J., Hajitou, A., Sarkis, Á. S., Arap, W., & Pasqualini, R. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.018 · Cited by 412
Rong, L., Li, Z., Leng, X., Li, H., Ma, Y., Chen, Y., & Song, F. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109726 · Cited by 244 · cited 1×
“study reported that Salidroside inhibited the growth of gastric cancer and induced apoptosis and protective autophagy through the PI3K/Akt/ mTOR pathway [24].”
BackgroundSelf-citationTan, L. P., Tan, G. W., Sivanesan, V. M., Goh, S. L., Ng, X. J., Lim, C. S., Kim, W. R., Mohidin, T. B. M., Dali, N. S. M., Ong, S. H., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32656 · Cited by 86
Salidroside inhibits the growth of human breast cancer in vitro and in vivo
ZHAO, G., SHI, A., FAN, Z., & DU, Y. (2015) · Oncology Reports · doi:10.3892/or.2015.3857 · Cited by 79 · cited 1×
“cyclophosphamide in the treatment of breast cancer and lung cancer effectively improves the antitumor and anti-metastasis efficacy [11,12].”
BackgroundGuo, W., Huang, Q., Feng, Y., Tan, T., Niu, S., Hou, S., Chen, Z., Du, Z., Shen, Y., & Fang, X. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27370 · Cited by 71
Curcumin enhances radiosensitization of nasopharyngeal carcinoma by regulating circRNA network
Yang, J., Zhu, D., Liu, S., Shao, M., Liu, Y., Li, A., Lv, Y., Huang, M. C., Lou, D., & Fan, Q. (2019) · Molecular Carcinogenesis · doi:10.1002/mc.23143 · Cited by 54
Self-citation
Research works printed but not linked: 1
- 10.1016/j.bbrc.2020.05.066 · DOI
Cited by
Drug repurposing for cancer therapy
Xia, Y., Sun, M., Huang, H., & Jin, W.-L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01808-1 · Cited by 443
“79 Similarly, Liu et al. showed that salidroside suppressed proliferation, colony formation, and migration of the PC3 and DU145 prostate cancer cell lines in a dose-dependent manner by inhibiting the PI3K/AKT pathway.”
BackgroundBernatonienė, J., Jakštas, V., & Kopustinskienė, D. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512293 · Cited by 96
Pharmacological effects of salidroside on central nervous system diseases
Jin, M., Wang, C., Xu, Y., Zhang, Z., Wu, X., Ye, R., Zhang, Q., & Han, D. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113746 · Cited by 68
New progresses on cell surface protein HSPA5/BiP/GRP78 in cancers and COVID-19
Li, T., Fu, J., Cheng, J., Elfiky, A. A., Wei, C., & Fu, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1166680 · Cited by 56
“Salidroside, an extract from Rhodiola roots (molecular formula: C14H20O7), was reported to suppress the activation of NPC cells by targeting the axis of miR4262/HSPA5 (43).”
BackgroundSun, Y.-M., Wang, X.-Y., Zhou, X.-R., Zhang, C., Liu, K.-J., Zhang, F.-Y., & Xiang, B. (2022) · Antioxidants · doi:10.3390/antiox11071414 · Cited by 20
“In normal cells, salidroside plays important roles in anti-inflammation, anti-stress, antioxidant, anti-aging, and anti-viral activities [46], while in cancer cells, salidroside inhibits cell proliferation and induces cell apoptosis, including urinary bladder cancer, breast cancer, gastric and colorectal cancer, lung…”
Background
Metadata
- Authors
- Liu, S., Li, Y., & Li, Z.
- Affiliations
- Zhejiang University (CN)
- Chinese People's Liberation Army (CN)
- Jinan Central Hospital (CN)
- Corresponding author
- Li, Zhaoxia
- Venue
- Cell Cycle
- Publisher
- Informa UK Limited
- Published
- 2022-02-27
- Volume
- 21
- Issue
- 7
- Pages
- 720-729
- ISSN
- 1538-4101 (ISSN-L)
- 1551-4005
- PMC
- PMC8973335
- OpenAlex
- W4214755490
- Semantic Scholar
- 43496369747a4884a9d6a7a97c8b5131f8d92f22
- Cited by
- 21
- References
- 35
- Citations by year
- 2026: 1 · 2025: 8 · 2024: 5 · 2023: 4 · 2022: 3
- FWCI
- 1.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Cell Cycle (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- autho
- Topics
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Bioactive Compounds
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Otorhinolaryngology › Head and Neck Cancer Studies
- Keywords
- salidroside, nasopharyngeal carcinoma, GRP78, cell proliferation, apoptosis, Bax/Bcl-2 ratio, tumor xenografts, microRNA target regulation
- MeSH terms
- Nasopharyngeal Carcinoma, Endoplasmic Reticulum Chaperone BiP, Animals, Glucosides, Humans, Mice, Nude, Nasopharyngeal Neoplasms, Phenols, Gene Expression Regulation, Neoplastic, Apoptosis, MicroRNAs, Cell Line, Tumor, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Salidroside suppresses the activation of nasopharyngeal carcinoma cells via targeting miR-4262/GRP78 axis. https://app.cochat.ai/papers/10.1080/15384101.2021.2019976
- The paper
- Liu, S., Li, Y., & Li, Z. (2022). Salidroside suppresses the activation of nasopharyngeal carcinoma cells via targeting miR-4262/GRP78 axis. Cell Cycle. https://doi.org/10.1080/15384101.2021.2019976
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.